Vicarious Surgical (RBOT) Stock Price, News & Analysis

Company Overview

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Key Stats

• Today's Range: $6.50 to $7.25
• 50-Day Range: $7.22 to $15.85
• 52-Week Range: $4.27 to $19.00
• Volume: 19,501 shs
• Average Volume: 33,281 shs
• Market Capitalization: $38.93 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $9.25
• Consensus Rating: Hold

Vicarious Surgical Stock Analysis - MarketRank™

Vicarious Surgical scored higher than 49% of companies evaluated by MarketBeat, and ranked 589th out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Vicarious Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Vicarious Surgical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Vicarious Surgical are expected to grow in the coming year, from ($10.89) to ($8.50) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Vicarious Surgical is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Vicarious Surgical is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Vicarious Surgical has a P/B Ratio of 0.39. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.20% of the float of Vicarious Surgical has been sold short.

Short Interest Ratio / Days to Cover

Vicarious Surgical has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Vicarious Surgical has recently increased by 3.61%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Vicarious Surgical does not currently pay a dividend.

Dividend Growth

Vicarious Surgical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.20% of the float of Vicarious Surgical has been sold short.

Short Interest Ratio / Days to Cover

Vicarious Surgical has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Vicarious Surgical has recently increased by 3.61%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

News Sentiment

Vicarious Surgical has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Vicarious Surgical this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for RBOT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

Only 2 people have added Vicarious Surgical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Vicarious Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $24,657.00 in company stock.

Percentage Held by Insiders

11.73% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

47.27% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

RBOT Stock Analysis - Frequently Asked Questions

How have RBOT shares performed this year?

Vicarious Surgical's stock was trading at $13.16 on January 1st, 2025. Since then, RBOT shares have decreased by 49.9% and is now trading at $6.59.
View the best growth stocks for 2025 here.

How were Vicarious Surgical's earnings last quarter?

Vicarious Surgical Inc (NYSE:RBOT) posted its quarterly earnings data on Monday, March, 17th. The company reported ($2.43) EPS for the quarter, topping the consensus estimate of ($2.69) by $0.26. The business earned $2.09 million during the quarter.

When did Vicarious Surgical's stock split?

Vicarious Surgical's stock reverse split before market open on Thursday, June 13th 2024. The 1-30 reverse split was announced on Thursday, June 13th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Who are Vicarious Surgical's major shareholders?

Top institutional investors of Vicarious Surgical include DDD Partners LLC (3.14%), Geode Capital Management LLC (0.52%), DnB Asset Management AS (0.36%) and Renaissance Technologies LLC (0.20%). Insiders that own company stock include Ventures V LP Khosla, Adam David Sachs, Sammy Khalifa, June Morris, William John Kelly, John Mazzola and Philip Liang.
View institutional ownership trends.

How do I buy shares of Vicarious Surgical?

Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Vicarious Surgical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vicarious Surgical investors own include NVIDIA (NVDA), Akoustis Technologies (AKTS), Advanced Micro Devices (AMD), PayPal (PYPL), Taiwan Semiconductor Manufacturing (TSM) and SoFi Technologies (SOFI).

Company Calendar

• Last Earnings: 3/17/2025
• Today: 3/27/2025
• Next Earnings (Estimated): 5/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical appliances & supplies
• Sub-Industry: N/A
• Current Symbol: NYSE:RBOT
• CIK: 1812173
• Web: www.vicarioussurgical.com
• Phone: 617 868 1700
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $9.25
• High Stock Price Target: $10.00
• Low Stock Price Target: $8.50
• Potential Upside/Downside: +40.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($10.85)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-71,070,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -81.46%
• Return on Assets: -63.62%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 7.44
• Quick Ratio: 7.44

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $16.76 per share
• Price / Book: 0.39

Miscellaneous

• Outstanding Shares: 5,908,000
• Free Float: 5,215,000
• Market Cap: $38.93 million
• Optionable: No Data
• Beta: 1.35